Literature DB >> 28334197

PPARα regulates tumor cell proliferation and senescence via a novel target gene carnitine palmitoyltransferase 1C.

Yixin Chen1, Yongtao Wang1, Yaoyao Huang1, Hang Zeng1, Bingfang Hu1, Lihuan Guan1, Huizhen Zhang1, Ai-Ming Yu2, Caroline H Johnson3, Frank J Gonzalez4, Min Huang, Huichang Bi1.   

Abstract

Carnitine palmitoyltransferase 1C (CPT1C), an enzyme located in the outer mitochondria membrane, has a crucial role in fatty acid transport and oxidation. It is also involved in cell proliferation and is a potential driver for cancer cell senescence. However, its upstream regulatory mechanism is unknown. Peroxisome proliferator activated receptor α (PPARα) is a ligand-activated transcription factor that regulates lipid metabolism and tumor progression. The current study aimed to elucidate whether and how PPARα regulates CPT1C and then affects cancer cell proliferation and senescence. Here, for the first time we report that PPARα directly activated CPT1C transcription and CPT1C was a novel target gene of PPARα, as revealed by dual-luciferase reporter and chromatin immunoprecipitation (ChIP) assays. Moreover, regulation of CPT1C by PPARα was p53-independent. We further confirmed that depletion of PPARα resulted in low CPT1C expression and then inhibited proliferation and induced senescence of MDA-MB-231 and PANC-1 tumor cell lines in a CPT1C-dependent manner, while forced PPARα overexpression promoted cell proliferation and reversed cellular senescence. Taken together, these results indicate that CPT1C is a novel PPARα target gene that regulates cancer cell proliferation and senescence. The PPARα-CPT1C axis may be a new target for the intervention of cancer cellular proliferation and senescence.
© The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28334197      PMCID: PMC6248526          DOI: 10.1093/carcin/bgx023

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  42 in total

Review 1.  The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis.

Authors:  J D McGarry; N F Brown
Journal:  Eur J Biochem       Date:  1997-02-15

2.  Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress.

Authors:  Kathrin Zaugg; Yi Yao; Patrick T Reilly; Karuppiah Kannan; Reza Kiarash; Jacqueline Mason; Ping Huang; Suzanne K Sawyer; Benjamin Fuerth; Brandon Faubert; Tuula Kalliomäki; Andrew Elia; Xunyi Luo; Vincent Nadeem; David Bungard; Sireesha Yalavarthi; Joseph D Growney; Andrew Wakeham; Yasmin Moolani; Jennifer Silvester; Annick You Ten; Walbert Bakker; Katsuya Tsuchihara; Shelley L Berger; Richard P Hill; Russell G Jones; Ming Tsao; Murray O Robinson; Craig B Thompson; Guohua Pan; Tak W Mak
Journal:  Genes Dev       Date:  2011-05-15       Impact factor: 11.361

Review 3.  Increased lipogenesis in cancer cells: new players, novel targets.

Authors:  Johannes V Swinnen; Koen Brusselmans; Guido Verhoeven
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2006-07       Impact factor: 4.294

4.  AMP-activated protein kinase induces a p53-dependent metabolic checkpoint.

Authors:  Russell G Jones; David R Plas; Sara Kubek; Monica Buzzai; James Mu; Yang Xu; Morris J Birnbaum; Craig B Thompson
Journal:  Mol Cell       Date:  2005-04-29       Impact factor: 17.970

Review 5.  New insights into the role of PPARs.

Authors:  Alexandra Montagner; Gianpaolo Rando; Gwendoline Degueurce; Nicolas Leuenberger; Liliane Michalik; Walter Wahli
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2011-07-20       Impact factor: 4.006

6.  Metabolic signatures uncover distinct targets in molecular subsets of diffuse large B cell lymphoma.

Authors:  Pilar Caro; Amar U Kishan; Erik Norberg; Illana A Stanley; Bjoern Chapuy; Scott B Ficarro; Klaudia Polak; Daniel Tondera; John Gounarides; Hong Yin; Feng Zhou; Michael R Green; Linfeng Chen; Stefano Monti; Jarrod A Marto; Margaret A Shipp; Nika N Danial
Journal:  Cancer Cell       Date:  2012-10-16       Impact factor: 31.743

7.  Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue- and inducer-specific manner.

Authors:  K Motojima; P Passilly; J M Peters; F J Gonzalez; N Latruffe
Journal:  J Biol Chem       Date:  1998-07-03       Impact factor: 5.157

Review 8.  The senescence-associated secretory phenotype: the dark side of tumor suppression.

Authors:  Jean-Philippe Coppé; Pierre-Yves Desprez; Ana Krtolica; Judith Campisi
Journal:  Annu Rev Pathol       Date:  2010       Impact factor: 23.472

Review 9.  Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects.

Authors:  Jean-Paul Bonnefont; Fatima Djouadi; Carina Prip-Buus; Stephanie Gobin; Arnold Munnich; Jean Bastin
Journal:  Mol Aspects Med       Date:  2004 Oct-Dec

10.  Carnitine palmitoyltransferase 1A functions to repress FoxO transcription factors to allow cell cycle progression in ovarian cancer.

Authors:  Huanjie Shao; Esraa M Mohamed; Guoyan G Xu; Michael Waters; Kai Jing; Yibao Ma; Yan Zhang; Sarah Spiegel; Michael O Idowu; Xianjun Fang
Journal:  Oncotarget       Date:  2016-01-26
View more
  19 in total

1.  Carnitine palmitoyltransferase 1C regulates cancer cell senescence through mitochondria-associated metabolic reprograming.

Authors:  Yongtao Wang; Yixin Chen; Lihuan Guan; Huizheng Zhang; Yaoyao Huang; Caroline H Johnson; Zeming Wu; Frank J Gonzalez; Aiming Yu; Peng Huang; Ying Wang; Shouhui Yang; Pan Chen; Xiaomei Fan; Min Huang; Huichang Bi
Journal:  Cell Death Differ       Date:  2018-01-09       Impact factor: 15.828

Review 2.  Peroxisome Proliferator-Activated Receptors and the Hallmarks of Cancer.

Authors:  Nicole Wagner; Kay-Dietrich Wagner
Journal:  Cells       Date:  2022-08-05       Impact factor: 7.666

3.  Metabolic modeling-based drug repurposing in Glioblastoma.

Authors:  Claudio Tomi-Andrino; Alina Pandele; Klaus Winzer; John King; Ruman Rahman; Dong-Hyun Kim
Journal:  Sci Rep       Date:  2022-07-01       Impact factor: 4.996

Review 4.  MicroRNAs: The Link between the Metabolic Syndrome and Oncogenesis.

Authors:  Adriana Fodor; Andrada Luciana Lazar; Cristina Buchman; Brandusa Tiperciuc; Olga Hilda Orasan; Angela Cozma
Journal:  Int J Mol Sci       Date:  2021-06-13       Impact factor: 5.923

Review 5.  The carnitine system and cancer metabolic plasticity.

Authors:  Mariarosa Anna Beatrice Melone; Anna Valentino; Sabrina Margarucci; Umberto Galderisi; Antonio Giordano; Gianfranco Peluso
Journal:  Cell Death Dis       Date:  2018-02-14       Impact factor: 8.469

6.  A novel miR-1291-ERRα-CPT1C axis modulates tumor cell proliferation, metabolism and tumorigenesis.

Authors:  Yixin Chen; Yanying Zhou; Fangwei Han; Yingyuan Zhao; Meijuan Tu; Yongtao Wang; Can Huang; Shicheng Fan; Panpan Chen; Xinpeng Yao; Lihuan Guan; Ai-Ming Yu; Frank J Gonzalez; Min Huang; Huichang Bi
Journal:  Theranostics       Date:  2020-06-01       Impact factor: 11.556

7.  Lipidomics reveals carnitine palmitoyltransferase 1C protects cancer cells from lipotoxicity and senescence.

Authors:  Huizhen Zhang; Yongtao Wang; Lihuan Guan; Yixin Chen; Panpan Chen; Jiahong Sun; Frank J Gonzalez; Min Huang; Huichang Bi
Journal:  J Pharm Anal       Date:  2020-04-21

Review 8.  The Involvement of PPARs in the Peculiar Energetic Metabolism of Tumor Cells.

Authors:  Andrea Antonosante; Michele d'Angelo; Vanessa Castelli; Mariano Catanesi; Dalila Iannotta; Antonio Giordano; Rodolfo Ippoliti; Elisabetta Benedetti; Annamaria Cimini
Journal:  Int J Mol Sci       Date:  2018-06-29       Impact factor: 5.923

9.  Arachidonic Acid Attenuates Cell Proliferation, Migration and Viability by a Mechanism Independent on Calcium Entry.

Authors:  Carlos Cantonero; Jose Sánchez-Collado; Jose J Lopez; Ginés M Salido; Juan A Rosado; Pedro C Redondo
Journal:  Int J Mol Sci       Date:  2020-05-07       Impact factor: 5.923

10.  Glioblastoma Utilizes Fatty Acids and Ketone Bodies for Growth Allowing Progression during Ketogenic Diet Therapy.

Authors:  Jantzen Sperry; Michael C Condro; Lea Guo; Daniel Braas; Nathan Vanderveer-Harris; Kristen K O Kim; Whitney B Pope; Ajit S Divakaruni; Albert Lai; Heather Christofk; Maria G Castro; Pedro R Lowenstein; Janel E Le Belle; Harley I Kornblum
Journal:  iScience       Date:  2020-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.